GALACTOSIDE INHIBITORS FOR NEW USES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15300769

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Calculated Rating
US Family Size
Non-US Coverage

Abstract

See full text

Provided is a method for treatment or prevention of α-synucleinopathies in a mammalian subject, the method comprising administering a therapeutically effective amount of at least one composition to the subject, wherein the composition comprises a molecule for pharmacological modulation of galectin activity in a mammalian brain.

First Claim

See full text

Other Claims data not available

Family

PCTEP
+

Patent Owner(s)

Patent OwnerAddress
GALECTO BIOTECH AB2200 COPENHAGEN

International Classification(s)

loading....
  • 2015 Application Filing Year
  • A61K Class
  • 16157 Applications Filed
  • 11882 Patents Issued To-Date
  • 73.55 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances201520162017201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DEIERBORG, Tomas Loddekopinge, SE 1 3
LEFFLER, Hakon Lund, SE 27 152
NILSSON, Ulf Lund, SE 114 736
SERRANO, Antonio Lund, SE 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 3 Citation Count
  • A61K Class
  • 45.09 % this patent is cited more than
  • 8 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges763281956782001332911183139501 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +050010001500200025003000350040004500500055006000650070007500800085009000

Forward Cite Landscape

Load Citation